CN Stock MarketDetailed Quotes

002826 Tibet Aim Pharm. Inc.

Watchlist
  • 8.13
  • -0.13-1.57%
Market Closed Jul 23 15:00 CST
1.55BMarket Cap44.43P/E (TTM)

Tibet Aim Pharm. Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-6.42%160.43M
-22.14%667.04M
-9.04%538.3M
-2.40%376.44M
-8.05%171.43M
18.10%856.73M
14.21%591.77M
13.86%385.71M
17.84%186.43M
20.38%725.46M
Operating revenue
-6.42%160.43M
-22.14%667.04M
-9.04%538.3M
-2.40%376.44M
-8.05%171.43M
18.10%856.73M
14.21%591.77M
13.86%385.71M
17.84%186.43M
20.38%725.46M
Other operating revenue
----
13.34%234.75K
----
-57.60%81.76K
----
-81.09%207.12K
----
--192.84K
----
133.83%1.1M
Total operating cost
-4.41%155.95M
-21.24%647.67M
-7.54%524.44M
-2.17%363.51M
-6.91%163.15M
16.77%822.31M
12.38%567.23M
11.52%371.59M
15.40%175.26M
21.48%704.22M
Operating cost
-33.20%63.77M
-32.25%325.59M
-16.70%275.48M
-5.07%206.73M
-8.96%95.47M
3.36%480.56M
-0.94%330.7M
-2.88%217.77M
5.26%104.86M
20.49%464.96M
Operating tax surcharges
13.12%3.56M
-4.35%11.52M
-4.36%9.49M
19.44%7.24M
-3.51%3.15M
14.66%12.05M
34.38%9.92M
31.96%6.06M
57.55%3.26M
30.40%10.51M
Operating expense
36.55%74.78M
-8.62%247.34M
-2.87%188.37M
-5.60%119.47M
-4.55%54.76M
56.85%270.67M
54.09%193.94M
60.00%126.56M
52.97%57.37M
20.78%172.57M
Administration expense
47.52%14.14M
7.97%51.01M
30.26%40.29M
24.06%24.41M
1.54%9.58M
2.91%47.25M
-1.26%30.93M
-0.00%19.67M
20.85%9.44M
29.79%45.91M
Financial expense
-83.36%-559.1K
4.20%-1.5M
45.81%-872.79K
58.91%-570.86K
56.75%-304.93K
-41.71%-1.57M
-167.96%-1.61M
-1,142.60%-1.39M
-283.25%-705.01K
-266.94%-1.11M
-Interest expense (Financial expense)
-79.39%84.74K
45.38%1.18M
280.01%1.11M
--886.97K
--411.11K
-3.86%810.56K
-65.01%290.86K
----
----
-47.87%843.14K
-Interest Income (Financial expense)
9.36%-662.34K
-12.04%-2.75M
-9.39%-2.13M
-12.49%-1.6M
-1.63%-730.76K
-21.65%-2.45M
-31.61%-1.95M
---1.42M
-13.64%-719.03K
-99.94%-2.01M
Research and development
-45.67%270.81K
2.68%13.71M
249.32%11.67M
113.03%6.24M
-51.49%498.45K
17.24%13.35M
-51.75%3.34M
-48.98%2.93M
-79.64%1.03M
66.33%11.39M
Credit Impairment Loss
-141.20%-723.13K
344.00%8.15M
437.97%2.26M
844.59%3.51M
334.06%1.76M
-183.56%-3.34M
-88.70%420.47K
-87.59%371.27K
-8,290.19%-749.84K
347.22%4M
Asset Impairment Loss
--812.52
-13,884.31%-19.8M
----
----
----
---141.62K
----
----
----
----
Other net revenue
1,054.21%27.92M
-80.60%4.13M
255.71%16.28M
90.44%5.29M
1,392.90%2.42M
-22.24%21.31M
-54.31%4.58M
-69.28%2.78M
-142.02%-187.12K
35.55%27.4M
Fair value change income
----
----
----
--151.39K
----
----
----
----
----
----
Invest income
---80.33K
56.14%2.31M
13.11%862.23K
68.26%654.78K
----
63.33%1.48M
-0.46%762.31K
-43.72%389.15K
----
65.93%906.93K
-Including: Investment income associates
----
--70.68K
----
----
----
----
----
----
----
----
Asset deal income
---15.72
--30.67K
----
----
----
----
71.79%-7.63K
50.04%-7.63K
-793.22%-7.63K
124.97%30.37K
Other revenue
4,225.10%28.73M
-42.30%13.45M
286.77%13.15M
-51.88%973.67K
16.45%664.16K
3.73%23.3M
-38.80%3.4M
-62.30%2.02M
341.95%570.35K
4.36%22.47M
Operating profit
202.80%32.39M
-57.82%23.5M
3.50%30.13M
7.79%18.21M
-2.67%10.7M
14.58%55.73M
24.28%29.12M
15.83%16.89M
62.16%10.99M
12.78%48.64M
Add:Non operating Income
155.19%148.52K
-31.22%1.24M
-52.04%343.69K
-81.34%120.87K
-72.16%58.2K
-41.60%1.8M
131.24%716.58K
677.01%647.66K
29.12%209.08K
-47.11%3.08M
Less:Non operating expense
-44.13%62.03K
38.46%1.14M
-32.33%626.06K
-45.55%266.76K
-63.98%111.02K
-51.56%824.78K
-39.15%925.13K
-39.63%489.96K
-40.80%308.21K
6.51%1.7M
Total profit
205.12%32.48M
-58.38%23.6M
3.27%29.85M
5.94%18.06M
-2.27%10.65M
13.38%56.7M
30.12%28.91M
23.06%17.05M
69.67%10.89M
5.63%50.01M
Less:Income tax cost
104.48%4.43M
-25.62%7.87M
-26.59%5.45M
-29.83%3.41M
-3.85%2.17M
61.89%10.59M
47.22%7.43M
32.17%4.86M
94.10%2.25M
4.51%6.54M
Net profit
230.83%28.05M
-65.90%15.73M
13.59%24.4M
20.20%14.65M
-1.86%8.48M
6.08%46.12M
25.09%21.48M
19.77%12.19M
64.28%8.64M
5.80%43.47M
Net profit from continuing operation
230.83%28.05M
-65.90%15.73M
13.59%24.4M
20.20%14.65M
-1.86%8.48M
6.08%46.12M
25.09%21.48M
19.77%12.19M
64.28%8.64M
5.80%43.47M
Less:Minority Profit
31.45%151.65K
-82.88%339.16K
117.30%511.84K
165.23%571.04K
3.75%115.37K
98.68%1.98M
496.38%235.55K
--215.3K
--111.2K
--996.82K
Net profit of parent company owners
233.58%27.9M
-65.14%15.39M
12.44%23.89M
17.59%14.08M
-1.93%8.36M
3.91%44.14M
24.00%21.25M
17.65%11.97M
62.16%8.53M
3.37%42.48M
Earning per share
Basic earning per share
275.00%0.15
-65.22%0.08
18.18%0.13
16.67%0.07
0.00%0.04
4.55%0.23
22.22%0.11
20.00%0.06
33.33%0.04
0.00%0.22
Diluted earning per share
275.00%0.15
-65.22%0.08
18.18%0.13
16.67%0.07
0.00%0.04
4.55%0.23
22.22%0.11
20.00%0.06
33.33%0.04
0.00%0.22
Other composite income
152.23%45.53K
9,900.68%365.53K
973.81%1.04M
13,152.84%1.42M
-3,652.98%-87.17K
80.01%-3.73K
1,953.02%96.88K
-22.44%-10.92K
-134.71%-2.32K
76.43%-18.65K
Other composite income of parent company owners
152.23%45.53K
9,900.68%365.53K
973.81%1.04M
13,152.84%1.42M
-3,652.98%-87.17K
80.01%-3.73K
1,953.02%96.88K
-22.44%-10.92K
-134.71%-2.32K
76.43%-18.65K
Total composite income
234.81%28.1M
-65.10%16.09M
17.90%25.44M
32.01%16.08M
-2.84%8.39M
6.12%46.11M
25.69%21.58M
19.76%12.18M
64.03%8.64M
5.96%43.45M
Total composite income of parent company owners
237.64%27.94M
-64.31%15.75M
16.80%24.93M
29.61%15.51M
-2.93%8.28M
3.94%44.13M
24.61%21.34M
17.65%11.96M
61.91%8.53M
3.53%42.46M
Total composite income of minority owners
31.45%151.65K
-82.88%339.16K
117.30%511.84K
165.23%571.04K
3.75%115.37K
98.68%1.98M
496.38%235.55K
--215.3K
--111.2K
--996.82K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -6.42%160.43M-22.14%667.04M-9.04%538.3M-2.40%376.44M-8.05%171.43M18.10%856.73M14.21%591.77M13.86%385.71M17.84%186.43M20.38%725.46M
Operating revenue -6.42%160.43M-22.14%667.04M-9.04%538.3M-2.40%376.44M-8.05%171.43M18.10%856.73M14.21%591.77M13.86%385.71M17.84%186.43M20.38%725.46M
Other operating revenue ----13.34%234.75K-----57.60%81.76K-----81.09%207.12K------192.84K----133.83%1.1M
Total operating cost -4.41%155.95M-21.24%647.67M-7.54%524.44M-2.17%363.51M-6.91%163.15M16.77%822.31M12.38%567.23M11.52%371.59M15.40%175.26M21.48%704.22M
Operating cost -33.20%63.77M-32.25%325.59M-16.70%275.48M-5.07%206.73M-8.96%95.47M3.36%480.56M-0.94%330.7M-2.88%217.77M5.26%104.86M20.49%464.96M
Operating tax surcharges 13.12%3.56M-4.35%11.52M-4.36%9.49M19.44%7.24M-3.51%3.15M14.66%12.05M34.38%9.92M31.96%6.06M57.55%3.26M30.40%10.51M
Operating expense 36.55%74.78M-8.62%247.34M-2.87%188.37M-5.60%119.47M-4.55%54.76M56.85%270.67M54.09%193.94M60.00%126.56M52.97%57.37M20.78%172.57M
Administration expense 47.52%14.14M7.97%51.01M30.26%40.29M24.06%24.41M1.54%9.58M2.91%47.25M-1.26%30.93M-0.00%19.67M20.85%9.44M29.79%45.91M
Financial expense -83.36%-559.1K4.20%-1.5M45.81%-872.79K58.91%-570.86K56.75%-304.93K-41.71%-1.57M-167.96%-1.61M-1,142.60%-1.39M-283.25%-705.01K-266.94%-1.11M
-Interest expense (Financial expense) -79.39%84.74K45.38%1.18M280.01%1.11M--886.97K--411.11K-3.86%810.56K-65.01%290.86K---------47.87%843.14K
-Interest Income (Financial expense) 9.36%-662.34K-12.04%-2.75M-9.39%-2.13M-12.49%-1.6M-1.63%-730.76K-21.65%-2.45M-31.61%-1.95M---1.42M-13.64%-719.03K-99.94%-2.01M
Research and development -45.67%270.81K2.68%13.71M249.32%11.67M113.03%6.24M-51.49%498.45K17.24%13.35M-51.75%3.34M-48.98%2.93M-79.64%1.03M66.33%11.39M
Credit Impairment Loss -141.20%-723.13K344.00%8.15M437.97%2.26M844.59%3.51M334.06%1.76M-183.56%-3.34M-88.70%420.47K-87.59%371.27K-8,290.19%-749.84K347.22%4M
Asset Impairment Loss --812.52-13,884.31%-19.8M---------------141.62K----------------
Other net revenue 1,054.21%27.92M-80.60%4.13M255.71%16.28M90.44%5.29M1,392.90%2.42M-22.24%21.31M-54.31%4.58M-69.28%2.78M-142.02%-187.12K35.55%27.4M
Fair value change income --------------151.39K------------------------
Invest income ---80.33K56.14%2.31M13.11%862.23K68.26%654.78K----63.33%1.48M-0.46%762.31K-43.72%389.15K----65.93%906.93K
-Including: Investment income associates ------70.68K--------------------------------
Asset deal income ---15.72--30.67K----------------71.79%-7.63K50.04%-7.63K-793.22%-7.63K124.97%30.37K
Other revenue 4,225.10%28.73M-42.30%13.45M286.77%13.15M-51.88%973.67K16.45%664.16K3.73%23.3M-38.80%3.4M-62.30%2.02M341.95%570.35K4.36%22.47M
Operating profit 202.80%32.39M-57.82%23.5M3.50%30.13M7.79%18.21M-2.67%10.7M14.58%55.73M24.28%29.12M15.83%16.89M62.16%10.99M12.78%48.64M
Add:Non operating Income 155.19%148.52K-31.22%1.24M-52.04%343.69K-81.34%120.87K-72.16%58.2K-41.60%1.8M131.24%716.58K677.01%647.66K29.12%209.08K-47.11%3.08M
Less:Non operating expense -44.13%62.03K38.46%1.14M-32.33%626.06K-45.55%266.76K-63.98%111.02K-51.56%824.78K-39.15%925.13K-39.63%489.96K-40.80%308.21K6.51%1.7M
Total profit 205.12%32.48M-58.38%23.6M3.27%29.85M5.94%18.06M-2.27%10.65M13.38%56.7M30.12%28.91M23.06%17.05M69.67%10.89M5.63%50.01M
Less:Income tax cost 104.48%4.43M-25.62%7.87M-26.59%5.45M-29.83%3.41M-3.85%2.17M61.89%10.59M47.22%7.43M32.17%4.86M94.10%2.25M4.51%6.54M
Net profit 230.83%28.05M-65.90%15.73M13.59%24.4M20.20%14.65M-1.86%8.48M6.08%46.12M25.09%21.48M19.77%12.19M64.28%8.64M5.80%43.47M
Net profit from continuing operation 230.83%28.05M-65.90%15.73M13.59%24.4M20.20%14.65M-1.86%8.48M6.08%46.12M25.09%21.48M19.77%12.19M64.28%8.64M5.80%43.47M
Less:Minority Profit 31.45%151.65K-82.88%339.16K117.30%511.84K165.23%571.04K3.75%115.37K98.68%1.98M496.38%235.55K--215.3K--111.2K--996.82K
Net profit of parent company owners 233.58%27.9M-65.14%15.39M12.44%23.89M17.59%14.08M-1.93%8.36M3.91%44.14M24.00%21.25M17.65%11.97M62.16%8.53M3.37%42.48M
Earning per share
Basic earning per share 275.00%0.15-65.22%0.0818.18%0.1316.67%0.070.00%0.044.55%0.2322.22%0.1120.00%0.0633.33%0.040.00%0.22
Diluted earning per share 275.00%0.15-65.22%0.0818.18%0.1316.67%0.070.00%0.044.55%0.2322.22%0.1120.00%0.0633.33%0.040.00%0.22
Other composite income 152.23%45.53K9,900.68%365.53K973.81%1.04M13,152.84%1.42M-3,652.98%-87.17K80.01%-3.73K1,953.02%96.88K-22.44%-10.92K-134.71%-2.32K76.43%-18.65K
Other composite income of parent company owners 152.23%45.53K9,900.68%365.53K973.81%1.04M13,152.84%1.42M-3,652.98%-87.17K80.01%-3.73K1,953.02%96.88K-22.44%-10.92K-134.71%-2.32K76.43%-18.65K
Total composite income 234.81%28.1M-65.10%16.09M17.90%25.44M32.01%16.08M-2.84%8.39M6.12%46.11M25.69%21.58M19.76%12.18M64.03%8.64M5.96%43.45M
Total composite income of parent company owners 237.64%27.94M-64.31%15.75M16.80%24.93M29.61%15.51M-2.93%8.28M3.94%44.13M24.61%21.34M17.65%11.96M61.91%8.53M3.53%42.46M
Total composite income of minority owners 31.45%151.65K-82.88%339.16K117.30%511.84K165.23%571.04K3.75%115.37K98.68%1.98M496.38%235.55K--215.3K--111.2K--996.82K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg